XML 42 R31.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of pre-tax compensation expense and the related income tax benefit for these stock-based incentives
Pre-tax compensation expense and the related income tax benefit for these stock-based incentives were as follows, in millions: 
 
Three Months Ended
March 31,
 
2016
 
2015
Long-term stock awards
$
5

 
$
6

Stock options
1

 
1

Phantom stock awards and stock appreciation rights
3

 
3

Total
$
9

 
$
10

Income tax benefit (37 percent tax rate)
$
3

 
$
4

Schedule of the Company's long-term stock award activity
Our long-term stock award activity was as follows, shares in millions: 
 
Three Months Ended
March 31,
 
2016
 
2015
Unvested stock award shares at January 1
5

 
6

Weighted average grant date fair value
$
17

 
$
18

 
 
 
 
Stock award shares granted
1

 
1

Weighted average grant date fair value
$
26

 
$
26

 
 
 
 
Stock award shares vested
2

 
2

Weighted average grant date fair value
$
16

 
$
17

 
 
 
 
Stock award shares forfeited

 

Weighted average grant date fair value
$
19

 
$
19

 
 
 
 
Unvested stock award shares at March 31
4

 
5

Weighted average grant date fair value
$
20

 
$
19


Schedule of the Company's stock option activity
Our stock option activity was as follows, shares in millions: 
 
 
Three Months Ended
March 31,
 
 
2016
 
 
2015
Option shares outstanding, January 1
 
12

 
 
18

Weighted average exercise price (A)
$
17

 
$
21

 
 
 
 
 
 
Option shares granted
 

 
 

Weighted average exercise price
$
26

 
$
26

 
 
 
 
 
 
Option shares exercised
 
1

 
 
1

Aggregate intrinsic value on date of exercise (B) 
$
18 million

 
$
17 million

Weighted average exercise price
$
18

 
$
14

 
 
 
 
 
 
Option shares forfeited
 

 
 

Weighted average exercise price
$

 
$
22

 
 
 
 
 
 
Option shares outstanding, March 31
 
11

 
 
17

Weighted average exercise price (A)
$
18

 
$
22

Weighted average remaining option term (in years)
 
4

 
 
3

 
 
 
 
 
 
Option shares vested and expected to vest, March 31
 
11

 
 
17

Weighted average exercise price (A)
$
18

 
$
22

Aggregate intrinsic value (B) 
$
154 million

 
$
108 million

Weighted average remaining option term (in years)
 
4

 
 
3

 
 
 
 
 
 
Option shares exercisable (vested), March 31
 
10

 
 
15

Weighted average exercise price (A)
$
17

 
$
22

Aggregate intrinsic value (B) 
$
138 million

 
$
94 million

Weighted average remaining option term (in years)
 
3

 
 
3

 
 
(A)
Subsequent to the separation of TopBuild, we modified our outstanding equity awards to employees and non-employee directors such that all individuals received an equivalent fair value both before and after the separation.  The modification contributed to the lower exercise price.
(B)
Aggregate intrinsic value is calculated using our stock price at each respective date, less the exercise price (grant date price) multiplied by the number of share.

Schedule of weighted average grant date fair value of option shares granted and the assumptions used to estimate those values using a Black-Scholes option pricing model
The weighted average grant date fair value of option shares granted and the assumptions used to estimate those values using a Black-Scholes option pricing model were as follows: 
 
Three Months Ended
March 31,
 
2016
 
2015
Weighted average grant date fair value
$
6.43

 
$
9.67

Risk-free interest rate
1.41
%
 
1.75
%
Dividend yield
1.49
%
 
1.32
%
Volatility factor
29.00
%
 
42.00
%
Expected option life
6 years

 
6 years